Blog
Daily evidence-led peptide research, regulatory news, expert digest and explainers. Every claim sourced; no AI tells.
Page 17
Peptides after surgery: the evidence
BPC-157, GHK-Cu and KPV get discussed as post-surgical recovery aids. No human trial has measured what any of them does to a healing surgical wound.
BPC-157, GHK-Cu and KPV after surgery
What the animal literature says about BPC-157, GHK-Cu, and KPV and post-surgical healing, and why the human evidence to guide restart timing does not yet exist.
PT-141 in women: onset and side effects
The RECONNECT Phase 3 trials enrolled 1,247 premenopausal women and documented onset timing, nausea rates, and the cardiovascular signal for bremelanotide.
Retatrutide's overstimulated side effects
Forum users describe a wired, foggy feeling on retatrutide. Here is what the phase 2 trials recorded, and the large gap between that and anecdote.
Retatrutide: the overstimulated side effect
Some retatrutide users report a wired, restless feeling during titration. The cause traces to GLP-1 receptor agonism activating brain sympathetic pathways.
Semax with armodafinil and nicotine
No published study has examined Semax alongside armodafinil or nicotine. Here is what the mechanisms suggest, and why silence is not a safety finding.
Semax and armodafinil: dopamine overlap
No interaction study covers semax, armodafinil and nicotine together. Here is what the pharmacology shows about dopaminergic overlap.
Thymosin β4 and pyroptosis in microglia
A July 2026 cell-culture study reports that thymosin beta-4 lowers pyroptosis markers in BV2 microglia. Here is what that does and does not show.
Tirzepatide in Sweden: import rules
In Sweden, tirzepatide (Mounjaro) is prescription-only and EU-authorised. Importing from outside the EEA requires dispensation and risks customs seizure.
Tirzepatide in Sweden: licence and cost
Mounjaro (tirzepatide) is licensed and prescribable in Sweden but sits outside the high-cost protection scheme. Here is what changed and what patients pay.
BPC-157 and TB-500 for back pain
BPC-157 and TB-500 show tissue-repair effects in animal models, but no human trial has tested either for chronic back pain.
BPC-157 and TB-4 blend: reconstitution math
How to reconstitute a BPC-157 and TB-4 lyophilised blend, what the arithmetic actually means, and why no validated human dose exists for either peptide.